These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3905687)

  • 1. Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs.
    Giraldi T; Sava G; Perissin L; Zorzet S; Decorti G; Steven FS
    Invasion Metastasis; 1985; 5(6):336-43. PubMed ID: 3905687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and inhibition by cytotoxic and antimetastatic drugs of cathepsin B-like cysteine proteinase in transplantable leukemias in mice.
    Giraldi T; Sava G; Zorzet S; Perissin L; Piccini P
    Anticancer Res; 1987; 7(3 Pt B):343-6. PubMed ID: 3307599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
    Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
    Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
    Leto G; Tumminello FM; Gebbia N; Woynarowska B; Bernacki RJ
    Anticancer Res; 1990; 10(1):265-9. PubMed ID: 2334138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK.
    Lassiani L; de Nardo MM; Nisi C; Varnavas A
    Farmaco Sci; 1988 Mar; 43(3):227-38. PubMed ID: 3417008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of patulin and structural analogs.
    Seigle-Murandi F; Steiman R; Krivobok S; Beriel H; Benoit-Guyod JL
    Pharmazie; 1992 Apr; 47(4):288-91. PubMed ID: 1518888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
    Bartholeyns J; Mamont P; Casara P
    Cancer Res; 1984 Nov; 44(11):4972-7. PubMed ID: 6435861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin induces the suppression of plasma neutral proteinase activity in mice: possible relationship to efficacy as an anti-inflammatory drug and induction of alterations in the immune system.
    Hart DA
    J Clin Lab Immunol; 1986 Aug; 20(4):199-205. PubMed ID: 3020255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
    Sava G; Zorzet S; Mestroni G; Zassinovich G
    Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
    Yoshida N; Kiyohara T; Fukui M; Atsumi T; Ogino S; Inaba M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1980 Oct; 40(10):3810-4. PubMed ID: 7438064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
    Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM
    Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
    Wang MC; Sharma RA; Bloch A
    Cancer Res; 1973 Jun; 33(6):1265-71. PubMed ID: 4578070
    [No Abstract]   [Full Text] [Related]  

  • 20. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.